Anastrozole 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQU1X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,290
Award facts
- Contract value 100% obligated
- $1,290.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,290.24 by the Defense Logistics Agency on January 12, 2026, for the supply of Anastrozole 1 mg tablets in quantities of 30 units. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The Defense Logistics Agency's Medical Supply Chain utilizes this IDC as a comprehensive global pharmaceutical support vehicle to fulfill medical procurement requirements for military healthcare programs. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and healthcare solutions provider, serves critical federal medical supply needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. The current award for Anastrozole—a hormone treatment medication—represents a routine task order fulfilling specific pharmaceutical inventory requirements within this broader framework that supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQU1X?
SPE2DR26FQU1X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FQU1X worth?
The government has obligated $1,290 on SPE2DR26FQU1X.
Is contract SPE2DR26FQU1X an order under another contract?
Yes. SPE2DR26FQU1X is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU1X competed?
The extent of competition for SPE2DR26FQU1X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award